
ACOG Annual Meeting Preview: 11 Trials for Primary Care
Details on 11 key abstracts with clinical relevance for primary care, from menopause management to cervical cancer screening.
The American College of Obstetricians and Gynecologists annual clinical and scientific meeting kicks off in Washington, DC, on Friday, May 1, 2026. It will showcase a range of research with clear implications for primary care. This year’s ACOG annual meeting boasts more than 4000 attendees, 400 speakers, and 500 sessions across the 3-day conference. The Patient Care Online editorial team will be on site at the conference, providing written coverage of practice-shifting data as well as interviews with key experts. You can keep up with our comprehensive conference coverage
Expert Interviews
Naima T. Joseph, MD, MPH, who will discuss late-breaking research she is presenting at the meeting.
Kimberly Sauchak Gecsi, MD and Akiva Pesach Novetsky, MD, MS, who will be discussing the latest and greatest in clinical guidelines.
Jill H. Liss, MD, who will be discussing clinical updates in menopause and vasomotor symptoms.
Trials to Watch
1. Preliminary analysis of real-world effects of fezolinetant on menopause-specific quality-of-life vasomotor symptoms (MENQOL VMS) overall and by subgroups of interest: Phase IV OPTION-VMS study
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Genevieve Neal-Perry, MD, PhD
2. Pooled Safety of Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause Across the US Population From 4 Placebo-Controlled Studies
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Barbara Yaeger
3. National Trends in Maternal Mortality From Obstetric Causes in the United States 2007-2023
Presentation time: 2:30pm on Sunday, May 3
Presenter(s): Ji Hea Byun
4. Neuro-hacking bone loss?: The Impact of Elinzanetant Treatment on Bone Health in Postmenopausal Women
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Sandra Hurtado, MD
5. Setting the Tone: Communication of Endometrial Cancer Diagnosis and Perceived Support at Treatment Initiation Among Black Women in the Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence Study
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Emma D. Wolfe
6. Sleep Disturbances and Menopausal Symptoms: Findings from the National Poll on Healthy Aging
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Joseph R. White, MD, MS
7. Menopause symptoms and cannabis use in a nationally representative sample of midlife women
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Emily L. Zhao
8. Smartphone-Based Artificial Intelligence Colposcopy for Cervical Cancer Screening in Low-Resource Settings- Protocol and Preliminary Findings from a Systematic Review and Meta-Analysis
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Nicole Friedlich, MD
9. Bacterial Vaginosis is Not an Independent Risk Factor for Human Papillomavirus Infection
Presentation time: 4:30pm on Saturday, May 2
Presenter(s): Erica Danielle Gan
10. Pneumococcal Vaccination Series Completion Among Eligible Pregnant Individuals
Presentation time: 8:00am on Friday, May 1
Presenter(s): Maria Cristina Marcos, MD
11. Trends in racial disparities in cervical cancer mortality in the 50 most populous U.S. counties
Presentation time: 1:30pm on Saturday, May 2
Presenter(s): Jasmine W. Jiang
Related Content


AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults


























































































